Cover Image
Market Research Report

Global mRNA Vaccines & Therapeutics Sales Market Report 2020

Published by QYResearch Product code 945417
Published Content info 140 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global mRNA Vaccines & Therapeutics Sales Market Report 2020
Published: September 2, 2020 Content info: 140 Pages
Description

Market Analysis and Insights: Global mRNA Vaccines & Therapeutics Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the mRNA Vaccines & Therapeutics market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

Global mRNA Vaccines & Therapeutics Scope and Market Size

The global mRNA Vaccines & Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines & Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2021-2032.

By Company

  • Moderna Therapeutics
  • CureVac
  • Translate Bio
  • BioNTech
  • Sangamo Therapeutics
  • Argos Therapeutics
  • In-Cell-Art
  • eTheRNA
  • Ethris
  • Tiba Biotechnology

Segment by Type

  • Infectious Disease Vaccines
  • Cancer Vaccines

Segment by Application

  • Infectious Disease
  • Cancer

By Region

  • North America
  • Europe
  • China
  • Japan
  • Korea
  • India
Table of Contents

TABLE OF CONTENTS

1 MRNA VACCINES & THERAPEUTICS MARKET OVERVIEW

  • 1.1 mRNA Vaccines & Therapeutics Product Scope
  • 1.2 mRNA Vaccines & Therapeutics Segment by Type
    • 1.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2021 & 2032)
    • 1.2.2 Infectious Disease Vaccines
    • 1.2.3 Cancer Vaccines
  • 1.3 mRNA Vaccines & Therapeutics Segment by Application
    • 1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application (2021-2032)
    • 1.3.2 Infectious Disease
    • 1.3.3 Cancer
  • 1.4 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts (2021-2032)
    • 1.4.1 Global mRNA Vaccines & Therapeutics Revenue Growth Rate (2021-2032)
    • 1.4.2 Global mRNA Vaccines & Therapeutics Sales Growth Rate (2021-2032)
    • 1.4.3 Global mRNA Vaccines & Therapeutics Price Trends (2021-2032)
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy

2 MRNA VACCINES & THERAPEUTICS ESTIMATES AND FORECASTS BY REGION

  • 2.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2021 VS 2027 VS 2032
  • 2.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region (2021-2026)
    • 2.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2026)
    • 2.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2021-2026)
  • 2.3 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Region (2027-2032)
    • 2.3.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts by Region (2027-2032)
    • 2.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2027-2032)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
    • 2.4.2 Europe mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
    • 2.4.3 China mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
    • 2.4.4 Japan mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
    • 2.4.5 Korea mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
    • 2.4.6 India mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)

3 MRNA VACCINES & THERAPEUTICS COMPETITION LANDSCAPE BY PLAYERS

  • 3.1 Manufacturers mRNA Vaccines & Therapeutics Headquarter, Founded Time
  • 3.2 Manufacturers mRNA Vaccines & Therapeutics Product Type, Research Stage, Treatment Area
  • 3.3 Main Pipeline Product Analysis
    • 3.3.1 IVAC-Mutanome
    • 3.3.2 FixVax
    • 3.3.3 CV8102
    • 3.3.4 CV7201
    • 3.3.5 AGS-004
    • 3.3.6 MRT5005 & MRT5201
    • 3.3.7 SB-FIX & SB-318 & SB-913
    • 3.3.8 Moderna Therapeutics Pipeline
  • 3.4 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3.5 Companies with mRNA Programs
    • 3.5.1 Alexion Pharmaceuticals
    • 3.5.2 Vertex Pharmaceuticals
    • 3.5.3 Ultragenyx Pharmaceutical
  • 3.6 Companies focus on mRNA Delivery
    • 3.6.1 Acuitas Therapeutics
    • 3.6.2 Silence Therapeutics
    • 3.6.3 Arcturus Therapeutics
  • 3.7 Major Pharmaceutical Companies with mRNA Programs
    • 3.7.1 Boehringer Ingelheim
    • 3.7.2 Novartis
    • 3.7.3 Merck
    • 3.7.4 AstraZeneca
    • 3.7.5 Roche
    • 3.7.6 Sanofi
    • 3.7.7 Takeda
    • 3.7.8 Johnson & Johnson
    • 3.7.9 Bayer
    • 3.7.10 ZIOPHARM Oncology
    • 3.7.11 MaxCyte
    • 3.7.12 Casebia Therapeutics
    • 3.7.13 Intellia Therapeutics

4 MRNA VACCINES & THERAPEUTICS MARKET SIZE BY TYPE

  • 4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2021-2026)
    • 4.1.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
    • 4.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2021-2026)
    • 4.1.3 Global mRNA Vaccines & Therapeutics Price by Type (2021-2026)
  • 4.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Type (2027-2032)
    • 4.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2027-2032)
    • 4.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2027-2032)
    • 4.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2027-2032)

5 MRNA VACCINES & THERAPEUTICS MARKET SIZE BY APPLICATION

  • 5.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2021-2026)
  • 5.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Application (2027-2032)

6 NORTH AMERICA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES

  • 6.1 North America mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
  • 6.2 North America mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)

7 EUROPE MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES

  • 7.1 Europe mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
  • 7.2 Europe mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)

8 CHINA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES

  • 8.1 China mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
  • 8.2 China mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)

9 JAPAN MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES

  • 9.1 Japan mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
  • 9.2 Japan mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)

10 KOREA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES

  • 10.1 Korea mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
  • 10.2 Korea mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)

11 INDIA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES

  • 11.1 India mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
  • 11.2 India mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)

12 ANALYSIS OF MRNA VACCINES & THERAPEUTICS INDUSTRY KEY MANUFACTURERS

  • 12.1 Moderna Therapeutics
    • 12.1.1 Company Profile
    • 12.1.2 Product Information
  • 12.2 CureVac
    • 12.2.1 Company Profile
    • 12.2.2 Product Information
  • 12.3 Translate Bio
    • 12.3.1 Company Profile
    • 12.3.2 Product Information
  • 12.4 BioNTech
    • 12.4.1 Company Profile
    • 12.4.2 Product Information
  • 12.5 Sangamo Therapeutics
    • 12.5.1 Company Profile
    • 12.5.2 Product Information
  • 12.6 Argos Therapeutics
    • 12.6.1 Company Profile
    • 12.6.2 Product Information
  • 12.7 In-Cell-Art
    • 12.7.1 Company Profile
    • 12.7.2 Product Information
  • 12.8 ETheRNA
    • 12.8.1 Company Profile
    • 12.8.2 Product Information
  • 12.9 Ethris
    • 12.9.1 Company Profile
    • 12.9.2 Product Information
  • 12.10 Tiba Biotechnology
    • 12.10.1 Company Profile
    • 12.10.2 Product Information

13 MRNA VACCINES & THERAPEUTICS MANUFACTURING COST ANALYSIS

  • 13.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials Price Trend
    • 13.1.2 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Comparison of Production Processes for Traditional, mRNA and DNA Vaccines
  • 13.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis

14 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 14.1 Marketing Channel
  • 14.2 mRNA Vaccines & Therapeutics Distributors List
  • 14.3 mRNA Vaccines & Therapeutics Customers

15 MARKET DYNAMICS

  • 15.1 Covid-19 Impact: mRNA Vaccines & Therapeutics Market Trends
  • 15.2 Covid-19 Impact: mRNA Vaccines & Therapeutics Opportunities and Drivers
  • 15.3 Covid-19 Impact: mRNA Vaccines & Therapeutics Market Challenges
  • 15.4 Porter's Five Forces Analysis

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

  • 17.1 Research Methodology
    • 17.1.1 Methodology/Research Approach
    • 17.1.2 Data Source
  • 17.2 Author Details
  • 17.3 Disclaimer

List of Tables and Figures

  • Table 1. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate by Type (2021 & 2032)
  • Table 2. Scope of Clinical mRNA Applications
  • Table 3. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate by Application (2021 & 2032)
  • Table 4. Overview of the World Economic Outlook Projections
  • Table 5. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
  • Table 6. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
  • Table 7. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
  • Table 8. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
  • Table 9. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
  • Table 10. Covid-19 Impact: Global Major Government Policy
  • Table 11. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2021 VS 2027 &2032
  • Table 12. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Region (2021-2026)
  • Table 13. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2026)
  • Table 14. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Region (2021-2026)
  • Table 15. Global mRNA Vaccines & Therapeutics Revenue Share by Region (2021-2026)
  • Table 16. Global mRNA Vaccines & Therapeutics Sales (M Doses) Forecast by Region (2027-2032)
  • Table 17. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2027-2032)
  • Table 18. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Forecast by Region (2027-2032)
  • Table 19. Global mRNA Vaccines & Therapeutics Revenue Share Forecast by Region (2027-2032)
  • Table 20. Manufacturers mRNA Vaccines & Therapeutics Headquarter, Founded Time
  • Table 21. Manufacturers mRNA Vaccines & Therapeutics Product Type, Research Stage, Treatment Area
  • Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 23. Alexion Pharmaceuticals Company Profile
  • Table 24. Vertex Pharmaceuticals Company Profile
  • Table 25. Ultragenyx Pharmaceutical Company Profile
  • Table 26. Acuitas Therapeutics Company Profile
  • Table 27. Silence Therapeutics Company Profile
  • Table 28. Product Information
  • Table 29. Arcturus Therapeutics Company Profile
  • Table 30. Product Information
  • Table 31. Boehringer Ingelheim Company Profile
  • Table 32. Novartis Company Profile
  • Table 33. Merck Company Profile
  • Table 34. AstraZeneca Company Profile
  • Table 35. Roche Company Profile
  • Table 36. Sanofi Company Profile
  • Table 37. Takeda Company Profile
  • Table 38. Johnson & Johnson Company Profile
  • Table 39. Bayer Company Profile
  • Table 40. ZIOPHARM Oncology Company Profile
  • Table 41. MaxCyte Company Profile
  • Table 42. Casebia Therapeutics Company Profile
  • Table 43. Intellia Therapeutics Company Profile
  • Table 44. Product Information
  • Table 45. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2021-2026)
  • Table 46. Global mRNA Vaccines & Therapeutics Sales Share by Type (2021-2026)
  • Table 47. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
  • Table 48. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2026)
  • Table 49. Global mRNA Vaccines & Therapeutics Price (M Doses) by Type (2021-2026)
  • Table 50. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2027-2032)
  • Table 51. Global mRNA Vaccines & Therapeutics Sales Share by Type (2027-2032)
  • Table 52. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2027-2032)
  • Table 53. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2027-2032)
  • Table 54. Global mRNA Vaccines & Therapeutics Price (M Doses) by Type (2027-2032)
  • Table 55. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2021-2026)
  • Table 56. Global mRNA Vaccines & Therapeutics Sales Share by Application (2021-2026)
  • Table 57. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2027-2032)
  • Table 58. Global mRNA Vaccines & Therapeutics Sales Share by Application (2027-2032)
  • Table 59. North America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
  • Table 60. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
  • Table 61. North America mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
  • Table 62. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
  • Table 63. North America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
  • Table 64. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
  • Table 65. North America mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
  • Table 66. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
  • Table 67. Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
  • Table 68. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
  • Table 69. Europe mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
  • Table 70. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
  • Table 71. Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
  • Table 72. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
  • Table 73. Europe mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
  • Table 74. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
  • Table 75. China mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
  • Table 76. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
  • Table 77. China mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
  • Table 78. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
  • Table 79. China mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
  • Table 80. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
  • Table 81. China mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
  • Table 82. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
  • Table 83. Japan mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
  • Table 84. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
  • Table 85. Japan mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
  • Table 86. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
  • Table 87. Japan mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
  • Table 88. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
  • Table 89. Japan mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
  • Table 90. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
  • Table 91. Korea mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
  • Table 92. Korea mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
  • Table 93. Korea mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
  • Table 94. Korea mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
  • Table 95. Korea mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
  • Table 96. Korea mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
  • Table 97. Korea mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
  • Table 98. Korea mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
  • Table 99. India mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
  • Table 100. India mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
  • Table 101. India mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
  • Table 102. India mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
  • Table 103. India mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
  • Table 104. India mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
  • Table 105. India mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
  • Table 106. India mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
  • Table 107. Moderna Therapeutics Company Profile
  • Table 108. CureVac Company Profile
  • Table 109. Translate Bio Company Profile
  • Table 110. BioNTech Company Profile
  • Table 111. Sangamo Therapeutics Company Profile
  • Table 112. Argos Therapeutics Company Profile
  • Table 113. In-Cell-Art Company Profile
  • Table 114. ETheRNA Company Profile
  • Table 115. Ethris Company Profile
  • Table 116. Tiba Biotechnology Company Profile
  • Table 117. Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound
  • Table 118. Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Table 119. mRNA Vaccines & Therapeutics Customers List
  • Table 120. Covid-19 Impact: mRNA Vaccines & Therapeutics Market Key Trends
  • Table 121. Covid-19 Impact: mRNA Vaccines & Therapeutics Key Opportunities and Drivers
  • Table 122. Covid-19 Impact: mRNA Vaccines & Therapeutics Market Challenges
  • Table 123. Research Programs/Design for This Report
  • Table 124. Key Data Information from Secondary Sources
  • Table 125. Key Data Information from Primary Sources
  • Figure 1. mRNA Vaccines & Therapeutics Product Picture
  • Figure 2. Global mRNA Vaccines & Therapeutics Market Share by Type in 2027
  • Figure 3. Global mRNA Vaccines & Therapeutics Market Share by Type in 2032
  • Figure 4. Global mRNA Vaccines & Therapeutics Market Share by Application in 2027
  • Figure 5. Global mRNA Vaccines & Therapeutics Market Share by Application in 2032
  • Figure 6. Infectious Disease Examples
  • Figure 7. Cancer Examples
  • Figure 8. Global mRNA Vaccines & Therapeutics Revenue, (US$ Million), 2021 VS 2027 VS 2032
  • Figure 9. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
  • Figure 10. Global mRNA Vaccines & Therapeutics Price Trends Growth Rate (2021-2032) & (USD/Doses)
  • Figure 11. Commodity Prices-Metals Price Indices
  • Figure 12. Commodity Prices- Precious Metal Price Indices
  • Figure 13. Commodity Prices- Agricultural Raw Material Price Indices
  • Figure 14. Commodity Prices- Food and Beverage Price Indices
  • Figure 15. Commodity Prices- Fertilizer Price Indices
  • Figure 16. Commodity Prices- Energy Price Indices
  • Figure 17. G20+: Economic Policy Responses to COVID-19
  • Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2021
  • Figure 19. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2026
  • Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2027
  • Figure 21. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2032
  • Figure 22. North America mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
  • Figure 23. North America mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
  • Figure 24. Europe mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
  • Figure 25. Europe mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
  • Figure 26. China mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
  • Figure 27. China mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
  • Figure 28. Japan mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
  • Figure 29. Japan mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
  • Figure 30. Korea mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
  • Figure 31. Korea mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
  • Figure 32. India mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
  • Figure 33. India mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
  • Figure 34. IVAC-Mutanome Pipeline
  • Figure 35. FixVax Pipeline
  • Figure 36. CV8102 Pipeline
  • Figure 37. CV7201 Pipeline
  • Figure 38. CV7201 Pipeline
  • Figure 39. MRT5005 & MRT5201 Pipeline
  • Figure 40. SB-FIX Pipeline
  • Figure 41. SB-318 & SB-913 Pipeline
  • Figure 42. Moderna Therapeutics Pipeline
  • Figure 43. mRNA Vaccines & Therapeutics Product Information of Acuitas Therapeutics
  • Figure 44. mRNA Vaccines & Therapeutics Product Information of ZIOPHARM Oncology
  • Figure 45. mRNA Vaccines & Therapeutics Product Information of Casebia Therapeutics
  • Figure 46. mRNA Vaccines & Therapeutics Product Picture of Moderna Therapeutics
  • Figure 47. mRNA Vaccines & Therapeutics Product Picture of CureVac
  • Figure 48. mRNA Vaccines & Therapeutics Product Picture of Translate Bio
  • Figure 49. mRNA Vaccines & Therapeutics Product Picture of BioNTech
  • Figure 50. mRNA Vaccines & Therapeutics Product Picture of Sangamo Therapeutics
  • Figure 51. mRNA Vaccines & Therapeutics Product Picture of Argos Therapeutics
  • Figure 52. mRNA Vaccines & Therapeutics Product Picture of In-Cell-Art
  • Figure 53. mRNA Vaccines & Therapeutics Product Picture of ETheRNA
  • Figure 54. mRNA Vaccines & Therapeutics Product Picture of Ethris
  • Figure 55. mRNA Vaccines & Therapeutics Product Picture of Tiba Biotechnology
  • Figure 56. Typical Phases from Research to the Market for a Cancer Vaccine Candidate
  • Figure 57. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
  • Figure 58. Comparison of Production Processes for Traditional, mRNA and DNA Vccines
  • Figure 59. Differences between Traditional, mRNA and DNA Vaccines
  • Figure 60. History of Vaccine Development
  • Figure 61. Differences between Traditional, MRNA and DNA Vaccines (Delivery)
  • Figure 62. mRNA Vaccines & Therapeutics Industrial Chain Analysis
  • Figure 63. Channels of Distribution
  • Figure 64. Distributors Profiles
  • Figure 65. Porter's Five Forces Analysis
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed
Back to Top